US 12317874
Method of using a genetically modified mouse that expresses human albumin
granted A61KA61K49/0008
Quick answer
US patent 12317874 (Method of using a genetically modified mouse that expresses human albumin) held by REGENERON PHARMACEUTICALS, INC. expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jun 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K49/0008